Here's a quick comparison: While dosing schedules appear similar, retatrutide's triple-receptor mechanism (GLP-1 + GIP + glucagon) produces different effects than dual-agonists like tirzepatide or single-agonists like semaglutide
Regular monitoring by your healthcare provider can help minimize these risks
Chronic joint or muscle discomfort Slow healing from injuries or surgeries Gastrointestinal issues such as leaky gut Sports-related injuries or high physical strain A consultation at Endocrinology Associates can help determine if BPC 157 is the right choice for your wellness goals
Stubborn weight gain during perimenopause or menopause Increased cravings or loss of appetite control Fatigue or slowed metabolism Weight that returns quickly after dieting Our approach goes beyond basic weight loss, targeting the hormonal and metabolic drivers that keep you stuck
For comprehensive cardiovascular assessment during metabolic peptide therapy, the peptides for anti-aging resource provides additional context on longevity-focused protocols
Sido B, Hack V, Hochlehnert A, et al
